newsfilter
← Latest News
GlobeNewswire·

INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update

BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient's innate